301 related articles for article (PubMed ID: 22491475)
1. NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens.
Yao Y; Wang Y; Chen F; Huang Y; Zhu S; Leng Q; Wang H; Shi Y; Qian Y
Cell Res; 2012 May; 22(5):836-47. PubMed ID: 22491475
[TBL] [Abstract][Full Text] [Related]
2. Expression regulation and function of NLRC5.
Yao Y; Qian Y
Protein Cell; 2013 Mar; 4(3):168-75. PubMed ID: 23483478
[TBL] [Abstract][Full Text] [Related]
3. Enhanced TLR-induced NF-κB signaling and type I interferon responses in NLRC5 deficient mice.
Tong Y; Cui J; Li Q; Zou J; Wang HY; Wang RF
Cell Res; 2012 May; 22(5):822-35. PubMed ID: 22473004
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8
Lupfer CR; Stokes KL; Kuriakose T; Kanneganti TD
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615208
[TBL] [Abstract][Full Text] [Related]
5. NLRC5 deficiency has a moderate impact on immunodominant CD8
Sun T; Ferrero RL; Girardin SE; Gommerman JL; Philpott DJ
Immunol Cell Biol; 2019 Jul; 97(6):552-562. PubMed ID: 30768806
[TBL] [Abstract][Full Text] [Related]
6. NLRC5 deficiency selectively impairs MHC class I- dependent lymphocyte killing by cytotoxic T cells.
Staehli F; Ludigs K; Heinz LX; Seguín-Estévez Q; Ferrero I; Braun M; Schroder K; Rebsamen M; Tardivel A; Mattmann C; MacDonald HR; Romero P; Reith W; Guarda G; Tschopp J
J Immunol; 2012 Apr; 188(8):3820-8. PubMed ID: 22412192
[TBL] [Abstract][Full Text] [Related]
7. Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.
Vijayan S; Sidiq T; Yousuf S; van den Elsen PJ; Kobayashi KS
Immunogenetics; 2019 Mar; 71(3):273-282. PubMed ID: 30706093
[TBL] [Abstract][Full Text] [Related]
8. NLRC5/MHC class I transactivator is a target for immune evasion in cancer.
Yoshihama S; Roszik J; Downs I; Meissner TB; Vijayan S; Chapuy B; Sidiq T; Shipp MA; Lizee GA; Kobayashi KS
Proc Natl Acad Sci U S A; 2016 May; 113(21):5999-6004. PubMed ID: 27162338
[TBL] [Abstract][Full Text] [Related]
9. T Cell Priming by Activated Nlrc5-Deficient Dendritic Cells Is Unaffected despite Partially Reduced MHC Class I Levels.
Rota G; Ludigs K; Siegert S; Tardivel A; Morgado L; Reith W; De Gassart A; Guarda G
J Immunol; 2016 Apr; 196(7):2939-46. PubMed ID: 26944927
[TBL] [Abstract][Full Text] [Related]
10. Hippo-signaling-controlled MHC class I antigen processing and presentation pathway potentiates antitumor immunity.
Peng L; Zhou L; Li H; Zhang X; Li S; Wang K; Yang M; Ma X; Zhang D; Xiang S; Duan Y; Wang T; Sun C; Wang C; Lu D; Qian M; Wang Z
Cell Rep; 2024 Apr; 43(4):114003. PubMed ID: 38527062
[TBL] [Abstract][Full Text] [Related]
11. NLRC5: a newly discovered MHC class I transactivator (CITA).
Meissner TB; Li A; Kobayashi KS
Microbes Infect; 2012 Jun; 14(6):477-84. PubMed ID: 22209772
[TBL] [Abstract][Full Text] [Related]
12. MHC class I transactivator NLRC5 in host immunity, cancer and beyond.
Cho SX; Vijayan S; Yoo JS; Watanabe T; Ouda R; An N; Kobayashi KS
Immunology; 2021 Mar; 162(3):252-261. PubMed ID: 32633419
[TBL] [Abstract][Full Text] [Related]
13. NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers.
Ong CEB; Patchett AL; Darby JM; Chen J; Liu GS; Lyons AB; Woods GM; Flies AS
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1973-1991. PubMed ID: 33797607
[TBL] [Abstract][Full Text] [Related]
14. Regulation of immune pathways by the NOD-like receptor NLRC5.
Lamkanfi M; Kanneganti TD
Immunobiology; 2012 Jan; 217(1):13-6. PubMed ID: 22024701
[TBL] [Abstract][Full Text] [Related]
15. Emerging Major Histocompatibility Complex Class I-Related Functions of NLRC5.
Chelbi ST; Dang AT; Guarda G
Adv Immunol; 2017; 133():89-119. PubMed ID: 28215281
[TBL] [Abstract][Full Text] [Related]
16. The balance between nuclear import and export of NLRC5 regulates MHC class I transactivation.
Zhu B; Ouda R; An N; Tanaka T; Kobayashi KS
J Biol Chem; 2024 May; 300(5):107205. PubMed ID: 38519032
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: impaired MHC class I expression in mice deficient for Nlrc5/class I transactivator.
Biswas A; Meissner TB; Kawai T; Kobayashi KS
J Immunol; 2012 Jul; 189(2):516-20. PubMed ID: 22711889
[TBL] [Abstract][Full Text] [Related]
18. Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins.
Robbins GR; Truax AD; Davis BK; Zhang L; Brickey WJ; Ting JP
J Biol Chem; 2012 Jul; 287(29):24294-303. PubMed ID: 22645137
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus Porcine Deltacoronavirus Upregulates MHC Class I Expression through RIG-I/IRF1-Mediated NLRC5 Induction.
Liu X; Yin L; Xue M; Chen J; Li L; Fu F; Feng L; Liu P
J Virol; 2022 Apr; 96(7):e0015822. PubMed ID: 35311551
[TBL] [Abstract][Full Text] [Related]
20. The discrepancy function of NLRC5 isoforms in antiviral and antibacterial immune responses.
Cao L; Wu XM; Hu YW; Xue NN; Nie P; Chang MX
Dev Comp Immunol; 2018 Jul; 84():153-163. PubMed ID: 29454830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
